FasT CAR-T GC012F
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FasT CAR-T GC012F, covering 2022-08-03 to 2022-08-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients [Phase 1, Phase 2]